From: Herman Landman [hjl25@juno.com]
Sent: Monday, March 19, 2001 2:38 PM
To: fdadockets@oc.fda.gov
Subject: Docket #00N-0989

Dear Sir or Madam:

I respectfully urge you to support the proposed  rule providing public
access on all new or ongoing clinical trials involving gene therapy or
xenotransplantation.

These are potentially dangerous areas that can threaten us all and all
information obtained must be available fpr public review.

                                                                         
        Sincerely yours,

                                                                         
                  Herman Landman